Credit: Insilico Medicine Insilico Medicine ("Insilico"), a clinical-stage artificial intelligence (AI)-driven drug discovery company, is announcing today the opening of ...
Insilico Medicine (“Insilico”), a clinical stage artificial intelligence (AI)-driven drug R&D company, today announces positive topline results of safety, tolerability, ...
Insilico Medicine (“Insilico”), a clinical stage, end-to-end artificial intelligence (AI)-driven drug discovery company, held the launch ceremony for Life Star – ...
Alex Zhavoronkov, PhD, founder and CEO of Insilico Medicine (“Insilico”), a clinical stage end-to-end artificial intelligence (AI)-driven drug discovery company, ...
Insilico Medicine (“Insilico”), a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, today announced that the company's drug discovery team ...
Insilico Medicine, a clinical stage end-to-end artificial intelligence (AI)-driven drug discovery company, today announces that leading AI analyst Margaretta Colangelo ...
Artificial intelligence (AI)-driven drug discovery company Insilico Medicine has announced a first-of-its-kind documentary hackathon called Docuthon to encourage creative scientific exploration. ...
Global analytics company Clarivate™ has named Insilico Medicine Founder and CEO Alex Zhavoronkov, PhD, as a Highly Cited Researcher for ...
Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, and the University of Copenhagen announced today the release ...
Insilico Medicine will present at the 41st Annual J.P. Morgan Healthcare Meeting happening Jan. 9-12, 2023 at the Westin St. Francis ...
Insilico Medicine, a clinical stage, end-to-end artificial intelligence (AI)-driven drug discovery company, is designing new non-hormonal contraceptive options for women ...
Insilico Medicine was named Company of the Year at the BioCentury-BayHelix East-West Summit on November 15. The clinical stage artificial ...
November 8, 2022, New York - Insilico Medicine, a clinical stage artificial intelligence (AI)-driven drug discovery company, announced a multi-year, ...
Andy Stamford, PhD, Vice President of Chemistry at Deerfield Discovery and Development at Deerfield Management, says he didn’t fully appreciate ...
The 9th annual Aging Research and Drug Discovery Conference, happening Aug. 29-Sept. 2 at the University of Copenhagen, will feature ...
● Insilico Medicine announces a closing of its Series D2 round, bringing the total Series D financing to $95 million, ...
July 19, 2022, New York---Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI) driven drug discovery company, has appointed Dr. Sujata ...
June 16th, 2022, Thursday (9.00AM EST), New York – Insilico Medicine, a global clinical-stage artificial intelligence (AI)-powered drug discovery and ...
NEW YORK, May 24, 2022 --- Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, today announced its nomination of ...
New York, April 13, 2022/PRNewswire/-- Insilico Medicine(“Insilico”), a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company today announced that the ...
